What is Morgan Scientific?
Morgan Scientific operates as a specialized provider of pulmonary function testing equipment, delivering high-precision tools such as spirometers and body boxes. Their flagship software, ComPAS2, serves as a cornerstone for clinical institutions, research facilities, and pediatric hospitals seeking reliable diagnostic data. The company distinguishes itself through a collaborative development model, where direct feedback from pulmonologists and academic researchers informs the evolution of their hardware and software ecosystem. By prioritizing accuracy and user-centric design, Morgan Scientific addresses the critical intersection of clinical efficacy and operational efficiency in respiratory care.
How much funding has Morgan Scientific raised?
Morgan Scientific has raised a total of $760K across 2 funding rounds:
Debt
$350K
Debt
$410K
Debt (2020): $350K with participation from PPP
Debt (2021): $410K led by PPP
Key Investors in Morgan Scientific
PPP
Public-Private Partnership
What's next for Morgan Scientific?
With the recent influx of capital, Morgan Scientific is well-positioned to accelerate its product development cycle and expand its market reach. The strategic focus will likely shift toward enhancing the interoperability of the ComPAS2 platform and deepening its penetration into large-scale healthcare networks. As the demand for advanced respiratory diagnostics grows, the company's ability to integrate customer-driven insights into its technological roadmap will be pivotal. Future growth will depend on maintaining the high reliability standards that have defined its reputation while navigating the complexities of enterprise-level medical device deployment.
See full Morgan Scientific company page
